Max pain is the price where the total value of all open calls and puts would be lowest at expiration, so option buyers as a group would lose the most. Some traders watch it as a level the stock may drift toward near expiration, because option sellers, often market makers, hedge their positions in ways that can pull the price toward heavily traded strikes. It is a theory, not a guarantee.

As of the Nov 4, 2026 close, max pain for Edwards Lifesciences options about one week from expiration was $90.28. The chart above shows the exact max pain for each expiration date.

Edwards Lifesciences closed above its near-term max pain on 13 of the last 20 trading days. On Nov 4, 2026 it closed at $99.38, 10.1% above max pain of $90.28.

Over the last 20 trading days, near-term max pain for Edwards Lifesciences ranged from $87.50 to $90.35. It went from $87.55 on Oct 8, 2026 to $90.28 on Nov 4, 2026. See the EW max pain history for a longer view.

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease.